GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 77 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $389,000 | -77.7% | 7,400 | -77.5% | 0.03% | -66.7% |
| Q1 2019 | $1,741,000 | -62.5% | 32,900 | -65.8% | 0.08% | -72.7% |
| Q1 2018 | $4,646,000 | +550.7% | 96,200 | +318.3% | 0.30% | +681.6% |
| Q3 2017 | $714,000 | +13.5% | 23,000 | 0.0% | 0.04% | -2.6% |
| Q2 2017 | $629,000 | +50.1% | 23,000 | -20.7% | 0.04% | +14.7% |
| Q4 2016 | $419,000 | -71.8% | 29,000 | -55.0% | 0.03% | -71.7% |
| Q3 2016 | $1,484,000 | -41.9% | 64,400 | -58.2% | 0.12% | -49.8% |
| Q2 2016 | $2,554,000 | +77.9% | 154,000 | +70.0% | 0.24% | +64.8% |
| Q1 2016 | $1,436,000 | +0.8% | 90,600 | +105.4% | 0.14% | -20.3% |
| Q4 2015 | $1,425,000 | – | 44,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |